Evaxion Biotech A/S(EVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EVAX Evaxion Biotech A/S

盘后交易 02-03 16:30:02 EST

3.19

+0.09

+2.90%

盘后3.19

+0.000.00%

16:04 EST

最高3.35	最低3.11	成交量8.45万
今开3.11	昨收3.10	日振幅7.74%
总市值2,649万	流通市值1,765万	总股本830.27万
成交额27.12万	换手率1.53%	流通股本553.19万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EVAX","market":"US","secType":"STK","nameCN":"Evaxion Biotech A/S","latestPrice":3.19,"timestamp":1770152400000,"preClose":3.1,"halted":0,"volume":84535,"hourTrading":{"tag":"盘后","latestPrice":3.19,"preClose":3.19,"latestTime":"16:04 EST","volume":772,"amount":2462.68,"timestamp":1770152689378,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.029032258064516082,"floatShares":5531900,"shares":8302700,"eps":-1.167371,"marketStatus":"盘后交易","change":0.09,"latestTime":"02-03 16:30:02 EST","open":3.11,"high":3.35,"low":3.11,"amount":271208.128818,"amplitude":0.077419,"askPrice":3.19,"askSize":50,"bidPrice":3.01,"bidSize":141,"shortable":3,"etf":0,"ttmEps":-1.167371,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770166800000},"marketStatusCode":4,"adr":0,"adrRate":50,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":3.1,"preHourTrading":{"tag":"盘前","latestPrice":3.1,"preClose":3.1,"latestTime":"08:43 EST","volume":641,"amount":1987.1000000000001,"timestamp":1770126214088,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":3.19,"preClose":3.19,"latestTime":"16:04 EST","volume":772,"amount":2462.68,"timestamp":1770152689378,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.789159,"impliedVol":2.1042,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/EVAX","defaultTab":"news","newsList":[{"id":"1181606810","title":"Evaxion Biotech A/S - 可获得最高达5.92亿美元的里程碑付款，以支持Evx-B3的开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1181606810","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181606810?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:09","pubTimestamp":1766146191,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S - 可获得最高达5.92亿美元的里程碑付款，以支持Evx-B3的开发","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1201861249.SGD","LU1162221912.USD","LU0477156953.USD","LU1066051811.HKD","LU1037948541.HKD","IE00BLSP4239.USD","SG9999014575.USD","LU2360032135.SGD","LU1917777945.USD","LU1974910355.USD","LU0980610538.SGD","LU0965508806.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","SG9999013999.USD","LU0265550946.USD","SG9999015341.SGD","LU1057294990.SGD","LU1934455277.USD","IE00BJT1NW94.SGD","LU2023250504.SGD","LU2125154778.USD","BK4007","LU1093756325.SGD","LU2361044865.SGD","LU0203345920.USD","LU0098860793.USD","LU1934455863.HKD","LU1989771016.USD","LU0320765489.SGD","BK4559","SG9999001176.USD","IE00BBT3K403.USD","LU1066051498.USD","LU1699723380.USD","LU1066051225.USD","LU0985320562.USD","LU2324357040.USD","BK4588","LU0965509101.SGD","SG9999014542.SGD","LU1941712348.USD","IE0002141913.USD","LU2361044949.HKD","LU2089984988.USD","LU1116320901.HKD","LU0861579265.USD","BK4516","LU2112291526.USD","IE00B2B36J28.USD","LU1989772923.USD","LU2461242641.AUD","BK4534","LU0130102774.USD","SG9999001440.SGD","IE00BSNM7G36.USD","LU1023059063.AUD","BK4550","LU0234572021.USD","LU1061106388.HKD","EVAX","LU1093756168.USD","IE00B1BXHZ80.USD","LU0203347892.USD","BK4585","IE000M9KFDE8.USD","LU1929549753.HKD","LU2125154935.USD","LU1585245621.USD","SG9999015358.SGD","SG9999002232.USD","LU0208291251.USD","LU2106854487.HKD","LU1291159041.SGD","LU0211331839.USD","LU1941712264.USD","LU0266013472.USD","LU1989772840.SGD","SG9999014567.USD","SGXZ57979304.SGD","LU0122379950.USD","LU1983299246.USD","LU1116320737.USD","IE0009355771.USD","LU0070302665.USD","LU2023250843.SGD","BK4139","LU0965509010.AUD","IE00BFTCPJ56.SGD","LU1934455194.USD","IE00BN8TJ469.HKD","LU2361045086.USD","LU0265550359.USD","LU0320765646.SGD","SG9999002224.SGD","LU1430594728.SGD","IE00BLSP4452.SGD","LU1035773651.USD","LU1066053197.SGD","LU0058720904.USD","SG9999001176.SGD","LU0648001328.SGD","LU0106261372.USD","SG9999014559.SGD","LU1571399168.USD","LU1037948897.HKD","LU1069347547.HKD","LU0965509283.SGD","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU0238689110.USD","LU0006306889.USD","BK4533","LU0130517989.USD"],"gpt_icon":0},{"id":"1135275259","title":"Evaxion Biotech A/S保留Evx-B2全球权利并寻求其他潜在许可合作伙伴","url":"https://stock-news.laohu8.com/highlight/detail?id=1135275259","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135275259?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:09","pubTimestamp":1766146151,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S保留Evx-B2的全球权利，并计划寻找另一个潜在的许可合作伙伴。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"1150348242","title":"Evaxion Biotech A/S：招股说明书涉及由出售股东提供和销售最多38,450,000股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1150348242","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150348242?lang=zh_cn&edition=full","pubTime":"2025-11-21 21:48","pubTimestamp":1763732901,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S：招股说明书涉及由出售股东提供和销售最多38,450,000股普通股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"1167788334","title":"Evaxion Biotech 第三季度基本每股收益为 0.01 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1167788334","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167788334?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:59","pubTimestamp":1763571558,"startTime":"0","endTime":"0","summary":"11月6日 - Evaxion Biotech 第三季度税前利润为 435.2万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"1117131298","title":"Evaxion Biotech A/S：Birgitte RØNØ将继续担任首席科学官一职","url":"https://stock-news.laohu8.com/highlight/detail?id=1117131298","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117131298?lang=zh_cn&edition=full","pubTime":"2025-10-27 20:04","pubTimestamp":1761566680,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S：Birgitte RØNØ将继续担任首席科学官一职","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"1145815482","title":"Evaxion Biotech A/S - 所有患者均观察到免疫激活，81%的Evx-01疫苗靶点触发了特定反应","url":"https://stock-news.laohu8.com/highlight/detail?id=1145815482","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145815482?lang=zh_cn&edition=full","pubTime":"2025-10-17 20:17","pubTimestamp":1760703430,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S - 所有患者均观察到免疫激活，81%的Evx-01疫苗靶点触发了特定反应","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"1135841656","title":"Evaxion生物科技A/S在第二阶段试验中报告AI设计个性化癌症疫苗Evx-01的75%客观缓解率","url":"https://stock-news.laohu8.com/highlight/detail?id=1135841656","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135841656?lang=zh_cn&edition=full","pubTime":"2025-10-17 20:17","pubTimestamp":1760703430,"startTime":"0","endTime":"0","summary":"Evaxion生物科技A/S在第二阶段试验中报告AI设计的个性化癌症疫苗Evx-01达到了75%的客观缓解率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"1117718036","title":"Evaxion Biotech A/S - 75%的客观反应率，16名晚期黑色素瘤患者中有12名显示出客观临床反应","url":"https://stock-news.laohu8.com/highlight/detail?id=1117718036","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117718036?lang=zh_cn&edition=full","pubTime":"2025-10-17 20:17","pubTimestamp":1760703429,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S - 75%的客观反应率，16名晚期黑色素瘤患者中有12名显示出客观临床反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"1101546742","title":"Evaxion Biotech A/S将获得750万美元现金支付，并有资格获得高达5.92亿美元销售里程碑付款及净销售版税","url":"https://stock-news.laohu8.com/highlight/detail?id=1101546742","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101546742?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:05","pubTimestamp":1758798320,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S将获得750万美元的现金支付，同时有资格获得高达5.92亿美元的销售里程碑付款，以及基于净销售额的版税收入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"1155195935","title":"Evaxion Biotech A/S：MSD将承担EVX-B3疫苗进一步开发的全部责任和所有费用","url":"https://stock-news.laohu8.com/highlight/detail?id=1155195935","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155195935?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:05","pubTimestamp":1758798319,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S：MSD将承担EVX-B3疫苗进一步开发的全部责任和所有费用","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2512164995","title":"Evaxion Biotech As盘中异动 早盘股价大涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512164995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512164995?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:48","pubTimestamp":1739893735,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时48分，Evaxion Biotech As股票出现波动，股价大幅上涨5.62%。截至发稿，该股报2.63美元/股，成交量12.8101万股，换手率2.04%，振幅6.83%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.75%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218234855a24abe46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218234855a24abe46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"gpt_icon":0},{"id":"2511918656","title":"Evaxion Biotech As盘中异动 急速下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511918656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511918656?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:51","pubTimestamp":1739544684,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时51分，Evaxion Biotech As股票出现异动，股价快速跳水5.17%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.42%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214225125a24605d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214225125a24605d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"gpt_icon":0},{"id":"2511525264","title":"Evaxion Biotech As盘中异动 快速上涨5.34%报2.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511525264?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:33","pubTimestamp":1739457213,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时33分，Evaxion Biotech As股票出现波动，股价快速拉升5.34%。截至发稿，该股报2.76美元/股，成交量2.5049万股，换手率0.40%，振幅0.00%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.17%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322333398842bf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322333398842bf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"gpt_icon":0},{"id":"2510808903","title":"Evaxion Biotech As盘中异动 股价大涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510808903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510808903?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:42","pubTimestamp":1739284974,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时42分，Evaxion Biotech As股票出现波动，股价快速拉升5.73%。Evaxion Biotech As股票所在的生物技术行业中，整体跌幅为1.34%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224254a241fd9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224254a241fd9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX","BK4139","OCEA"],"gpt_icon":0},{"id":"2510863263","title":"Evaxion Biotech As盘中异动 股价大跌6.59%报2.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510863263?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:31","pubTimestamp":1739197896,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分，Evaxion Biotech As股票出现波动，股价急速下跌6.59%。截至发稿，该股报2.41美元/股，成交量11.4004万股，换手率1.82%，振幅3.10%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.38%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223136a240a1d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223136a240a1d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"gpt_icon":0},{"id":"2509285977","title":"Evaxion Biotech As盘中异动 股价大跌5.09%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509285977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509285977?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:24","pubTimestamp":1738941840,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时24分，Evaxion Biotech As股票出现异动，股价急速跳水5.09%。截至发稿，该股报2.61美元/股，成交量23.4843万股，换手率3.75%，振幅6.55%。Evaxion Biotech As股票所在的生物技术行业中，整体涨幅为0.15%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207232401987db78c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207232401987db78c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"gpt_icon":0},{"id":"2509277129","title":"Evaxion Biotech As盘中异动 早盘急速下挫5.69%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509277129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509277129?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:31","pubTimestamp":1738852292,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时31分，Evaxion Biotech As股票出现异动，股价急速下跌5.69%。截至发稿，该股报2.82美元/股，成交量11.5462万股，换手率1.84%，振幅0.67%。Evaxion Biotech As股票所在的生物技术行业中，整体跌幅为0.12%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223132abc4d44d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223132abc4d44d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"gpt_icon":0},{"id":"2509555469","title":"Lake Street：维持Evaxion Biotech(EVAX.US)评级，由买入调整至买入评级, 目标价由35.00美元调整至6.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509555469","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509555469?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:21","pubTimestamp":1738686095,"startTime":"0","endTime":"0","summary":"Lake Street：维持Evaxion Biotech(EVAX.US)评级，由买入调整至买入评级, 目标价由35.00美元调整至6.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/05002147950146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["EVAX"],"gpt_icon":0},{"id":"2508576754","title":"Evaxion Biotech As盘中异动 早盘股价大涨55.42%报3.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508576754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508576754?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:32","pubTimestamp":1738679531,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时32分，Evaxion Biotech As股票出现异动，股价急速上涨55.42%。截至发稿，该股报3.73美元/股，成交量4275.67万股，换手率682.30%，振幅12.50%。Evaxion Biotech As股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Azitra Inc、Evaxion Biotech As、Invivyd, Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为883.46%、684.08%、185.92%，振幅较大的相关个股有Azitra Inc、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Omega Therapeutics, Inc.，振幅分别为25.82%、19.74%、18.97%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223212a23928e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223212a23928e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"gpt_icon":0},{"id":"2508914969","title":"Evaxion Biotech As盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508914969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508914969?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:36","pubTimestamp":1738593371,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时36分，Evaxion Biotech As股票出现波动，股价急速下跌5.09%。截至发稿，该股报2.33美元/股，成交量3.6203万股，换手率0.58%，振幅2.44%。Evaxion Biotech As股票所在的生物技术行业中，整体跌幅为0.35%。Evaxion Biotech As公司简介：Evaxion Biotech AS 是一家临床阶段的生物技术公司，致力于探索人工智能或 AI，开发与目前上市产品相比疗效更好的免疫疗法，以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223611a2380ad7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223611a2380ad7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evaxionbiotech.com","stockEarnings":[{"period":"1week","weight":-0.2051},{"period":"1month","weight":-0.3418},{"period":"3month","weight":-0.4464},{"period":"6month","weight":0.0954},{"period":"1year","weight":0.2627},{"period":"ytd","weight":-0.3501}],"compareEarnings":[{"period":"1week","weight":0.0039},{"period":"1month","weight":0.0179},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.099},{"period":"1year","weight":0.1555},{"period":"ytd","weight":0.0198}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Evaxion A/S根据丹麦王国的法律于2008年8月11日成立。该公司是一家临床阶段公司，利用其专有的人工智能或AI、技术、工程专业知识和药物开发知识来模拟人体免疫系统并生成预测模型，以识别和开发用于治疗各种癌症、细菌性疾病和病毒感染的新免疫疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.312391},{"month":2,"riseRate":0,"avgChangeRate":-0.078845},{"month":3,"riseRate":0,"avgChangeRate":-0.116351},{"month":4,"riseRate":0.6,"avgChangeRate":0.075553},{"month":5,"riseRate":0.4,"avgChangeRate":0.067918},{"month":6,"riseRate":0.2,"avgChangeRate":-0.044814},{"month":7,"riseRate":0.4,"avgChangeRate":0.060856},{"month":8,"riseRate":0.6,"avgChangeRate":-0.04913},{"month":9,"riseRate":1,"avgChangeRate":0.19717},{"month":10,"riseRate":0.4,"avgChangeRate":0.102065},{"month":11,"riseRate":0.2,"avgChangeRate":-0.236379},{"month":12,"riseRate":0,"avgChangeRate":-0.21322}],"exchange":"NASDAQ","name":"Evaxion Biotech A/S","nameEN":"Evaxion Biotech A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evaxion Biotech A/S(EVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Evaxion Biotech A/S(EVAX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Evaxion Biotech A/S,EVAX,Evaxion Biotech A/S股票,Evaxion Biotech A/S股票老虎,Evaxion Biotech A/S股票老虎国际,Evaxion Biotech A/S行情,Evaxion Biotech A/S股票行情,Evaxion Biotech A/S股价,Evaxion Biotech A/S股市,Evaxion Biotech A/S股票价格,Evaxion Biotech A/S股票交易,Evaxion Biotech A/S股票购买,Evaxion Biotech A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evaxion Biotech A/S(EVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Evaxion Biotech A/S(EVAX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}